Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 65

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 65
---
$%20252024$%Interest expense$(1,874)$(3,783)$1,909 50%$(3,726)$(7,343)$3,617 49%Change in fair value of derivative liabilities990 3,717 (2,727)73%(3,911)1,216 (5,127)422%Gain on extinguishment of debt- 5,310 (5,310)-%- 5,205 (5,205)-%Other expense(27)(685)658 96%(28)(787)759 96%Other income89 10 79 790%181 2,800 (2,619)(94%)Other (expense) income, net$(822)$4,569 $(5,391)118%$(7,484)$1,091 $(8,575)786%

Other (expense) income, net decreased by $5.4 million to other expense of $0.8 million for the three months ended June 30, 2025, as compared to other income of $4.6 million for the same period of 2024. The decrease was primarily driven by a decrease in gain on extinguishment of debt of $5.3 million and a decrease from the change in the fair value of derivative liabilities of $2.7 million, partially offset by a decrease in interest expense of $1.9 million.  The change in fair value of derivative liability relates to the valuation of warrants previously issued by the Company. 

Other (expense) income, net decreased by $8.6 million to an expense of $7.5 million for the six months ended June 30, 2025, as compared to other income of $1.1 million for the same period of 2024. The decrease was primarily driven by a decrease in gain on extinguishment of debt of $5.2 million and a decrease from the change in the fair value of derivative liabilities of $5.1 million, partially offset by a decrease in interest expense of $3.6 million.  The change in fair value of derivative liability relates to the valuation of warrants previously issued by the Company. Other income for the six months ended June 30, 2024 mainly consists of the one-time payment of $2.5 million related to the Patent and License Agreement as described in Note 16.

Liquidity and Capital Resources

From inception through the year ended December 31, 202